Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Pancreatic Ductal | 25 | 2024 | 1755 | 3.170 |
Why?
|
Neoplastic Cells, Circulating | 26 | 2022 | 957 | 2.950 |
Why?
|
Pancreatic Neoplasms | 36 | 2024 | 5443 | 2.890 |
Why?
|
Tumor Microenvironment | 22 | 2024 | 3939 | 1.650 |
Why?
|
In Situ Hybridization | 14 | 2021 | 1905 | 1.300 |
Why?
|
Liver Diseases | 3 | 2020 | 1304 | 1.070 |
Why?
|
Adenocarcinoma, Mucinous | 3 | 2022 | 526 | 1.050 |
Why?
|
Colonic Neoplasms | 8 | 2024 | 2544 | 0.940 |
Why?
|
Carcinoma, Hepatocellular | 8 | 2024 | 2336 | 0.870 |
Why?
|
RNA, Satellite | 2 | 2022 | 16 | 0.860 |
Why?
|
Repetitive Sequences, Nucleic Acid | 4 | 2018 | 781 | 0.830 |
Why?
|
Gene Expression Regulation, Neoplastic | 24 | 2024 | 8634 | 0.780 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2022 | 223 | 0.770 |
Why?
|
Liver Neoplasms | 9 | 2024 | 4365 | 0.760 |
Why?
|
Epithelial-Mesenchymal Transition | 9 | 2024 | 755 | 0.760 |
Why?
|
RNA, Neoplasm | 7 | 2019 | 750 | 0.740 |
Why?
|
Epithelial Cells | 7 | 2020 | 3695 | 0.690 |
Why?
|
HMGA2 Protein | 1 | 2020 | 101 | 0.680 |
Why?
|
Cell Line, Tumor | 35 | 2024 | 17135 | 0.620 |
Why?
|
Adenocarcinoma | 13 | 2024 | 6406 | 0.600 |
Why?
|
Chimerism | 1 | 2019 | 156 | 0.600 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2019 | 959 | 0.560 |
Why?
|
Carcinoma, Papillary | 2 | 2024 | 793 | 0.550 |
Why?
|
Research Support as Topic | 1 | 2020 | 696 | 0.510 |
Why?
|
DNA, Satellite | 2 | 2015 | 67 | 0.490 |
Why?
|
Serum Albumin | 2 | 2015 | 676 | 0.490 |
Why?
|
Azacitidine | 1 | 2017 | 336 | 0.490 |
Why?
|
RNA-Binding Proteins | 2 | 2021 | 1883 | 0.480 |
Why?
|
Colorectal Neoplasms | 8 | 2023 | 6971 | 0.470 |
Why?
|
RNA | 8 | 2024 | 2726 | 0.420 |
Why?
|
Cholangiocarcinoma | 4 | 2022 | 562 | 0.410 |
Why?
|
Leucovorin | 7 | 2024 | 643 | 0.410 |
Why?
|
Neoplasm Metastasis | 8 | 2022 | 4921 | 0.410 |
Why?
|
RNA, Untranslated | 2 | 2015 | 457 | 0.380 |
Why?
|
Precancerous Conditions | 2 | 2017 | 984 | 0.370 |
Why?
|
Single-Cell Analysis | 9 | 2024 | 2533 | 0.370 |
Why?
|
Receptors, Androgen | 6 | 2018 | 1083 | 0.370 |
Why?
|
Sequence Analysis, RNA | 13 | 2024 | 2038 | 0.370 |
Why?
|
Ovarian Neoplasms | 3 | 2023 | 4907 | 0.340 |
Why?
|
Mice, Inbred NOD | 6 | 2020 | 1839 | 0.340 |
Why?
|
MicroRNAs | 3 | 2020 | 3804 | 0.340 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2783 | 0.330 |
Why?
|
Neoadjuvant Therapy | 9 | 2024 | 2909 | 0.330 |
Why?
|
Fluorouracil | 7 | 2024 | 1655 | 0.330 |
Why?
|
Cell Separation | 6 | 2017 | 1726 | 0.320 |
Why?
|
Humans | 123 | 2024 | 768393 | 0.310 |
Why?
|
Mice, SCID | 5 | 2022 | 2632 | 0.310 |
Why?
|
RNA, Messenger | 7 | 2022 | 12805 | 0.310 |
Why?
|
Graft vs Tumor Effect | 1 | 2008 | 68 | 0.300 |
Why?
|
Bile Duct Neoplasms | 3 | 2022 | 616 | 0.300 |
Why?
|
Coculture Techniques | 2 | 2024 | 1342 | 0.290 |
Why?
|
Barrett Esophagus | 2 | 2023 | 494 | 0.290 |
Why?
|
Interferons | 2 | 2022 | 716 | 0.290 |
Why?
|
Lymphocyte Transfusion | 1 | 2008 | 232 | 0.280 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 10 | 2024 | 11854 | 0.280 |
Why?
|
Long Interspersed Nucleotide Elements | 4 | 2023 | 332 | 0.280 |
Why?
|
Extracellular Matrix | 1 | 2014 | 1739 | 0.270 |
Why?
|
Transplantation Chimera | 2 | 2008 | 594 | 0.270 |
Why?
|
Immunohistochemistry | 13 | 2024 | 11120 | 0.270 |
Why?
|
Xenograft Model Antitumor Assays | 7 | 2024 | 3617 | 0.250 |
Why?
|
DNA Mismatch Repair | 3 | 2024 | 433 | 0.250 |
Why?
|
DNA Methylation | 3 | 2017 | 4421 | 0.250 |
Why?
|
Stromal Cells | 3 | 2021 | 1337 | 0.250 |
Why?
|
Breast Neoplasms | 13 | 2022 | 21162 | 0.240 |
Why?
|
Biomedical Research | 1 | 2020 | 3464 | 0.230 |
Why?
|
Cell Communication | 5 | 2024 | 1660 | 0.230 |
Why?
|
Transplantation Conditioning | 2 | 2008 | 1600 | 0.230 |
Why?
|
Mice | 32 | 2024 | 82017 | 0.230 |
Why?
|
Female | 62 | 2024 | 397089 | 0.230 |
Why?
|
Prognosis | 16 | 2024 | 30022 | 0.220 |
Why?
|
beta 2-Microglobulin | 1 | 2024 | 329 | 0.220 |
Why?
|
Animals | 38 | 2024 | 169337 | 0.220 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2024 | 146 | 0.220 |
Why?
|
Drug Resistance, Neoplasm | 8 | 2024 | 5336 | 0.210 |
Why?
|
Organoplatinum Compounds | 2 | 2015 | 408 | 0.210 |
Why?
|
Myofibroblasts | 1 | 2024 | 229 | 0.210 |
Why?
|
Alkylating Agents | 1 | 2023 | 132 | 0.210 |
Why?
|
Retroelements | 1 | 2023 | 162 | 0.200 |
Why?
|
GPI-Linked Proteins | 1 | 2024 | 473 | 0.200 |
Why?
|
Genomic Instability | 2 | 2016 | 715 | 0.200 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2022 | 213 | 0.190 |
Why?
|
RNA, Viral | 3 | 2021 | 2866 | 0.190 |
Why?
|
Male | 53 | 2024 | 364902 | 0.190 |
Why?
|
Microfluidics | 3 | 2017 | 674 | 0.190 |
Why?
|
Cell Differentiation | 3 | 2016 | 11668 | 0.190 |
Why?
|
Life Cycle Stages | 1 | 2022 | 161 | 0.190 |
Why?
|
Carcinoma | 2 | 2023 | 2341 | 0.190 |
Why?
|
Esophageal Neoplasms | 2 | 2023 | 1676 | 0.190 |
Why?
|
Collagen Type I | 1 | 2024 | 620 | 0.180 |
Why?
|
Microfluidic Analytical Techniques | 3 | 2017 | 823 | 0.180 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 6 | 2024 | 1105 | 0.180 |
Why?
|
Organoids | 3 | 2024 | 746 | 0.180 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2023 | 2952 | 0.180 |
Why?
|
Neuroendocrine Tumors | 2 | 2019 | 658 | 0.180 |
Why?
|
Gene Expression Profiling | 6 | 2024 | 9510 | 0.180 |
Why?
|
Glioma | 3 | 2020 | 3526 | 0.180 |
Why?
|
Microglia | 2 | 2020 | 1374 | 0.180 |
Why?
|
Bone Neoplasms | 3 | 2019 | 2565 | 0.180 |
Why?
|
Lamivudine | 1 | 2022 | 367 | 0.180 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2020 | 58 | 0.180 |
Why?
|
Signal Transduction | 11 | 2024 | 23631 | 0.180 |
Why?
|
Glioblastoma | 3 | 2020 | 3526 | 0.180 |
Why?
|
Endopeptidases | 1 | 2024 | 765 | 0.170 |
Why?
|
DNA, Neoplasm | 2 | 2019 | 1748 | 0.170 |
Why?
|
Wnt Proteins | 2 | 2015 | 724 | 0.170 |
Why?
|
Kaplan-Meier Estimate | 6 | 2020 | 6541 | 0.170 |
Why?
|
Chromatin Assembly and Disassembly | 2 | 2014 | 632 | 0.170 |
Why?
|
Transferrin | 1 | 2020 | 285 | 0.170 |
Why?
|
Tumor Cells, Cultured | 5 | 2021 | 6132 | 0.160 |
Why?
|
Endothelial Cells | 2 | 2024 | 3587 | 0.160 |
Why?
|
RNA Stability | 1 | 2021 | 321 | 0.160 |
Why?
|
Middle Aged | 32 | 2024 | 223491 | 0.160 |
Why?
|
Placenta Diseases | 1 | 2021 | 199 | 0.160 |
Why?
|
Lymphoma | 1 | 2008 | 1907 | 0.160 |
Why?
|
Lipogenesis | 1 | 2020 | 216 | 0.160 |
Why?
|
Interspersed Repetitive Sequences | 1 | 2019 | 52 | 0.160 |
Why?
|
Brain Neoplasms | 4 | 2020 | 9198 | 0.160 |
Why?
|
Oligonucleotides, Antisense | 1 | 2021 | 461 | 0.160 |
Why?
|
Prostatic Neoplasms | 8 | 2022 | 11221 | 0.160 |
Why?
|
Aged | 27 | 2024 | 171562 | 0.160 |
Why?
|
Neoplasms | 7 | 2018 | 22385 | 0.160 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2021 | 2185 | 0.160 |
Why?
|
Acetamides | 1 | 2020 | 260 | 0.160 |
Why?
|
Cell Movement | 4 | 2020 | 5215 | 0.150 |
Why?
|
Retroperitoneal Space | 1 | 2019 | 173 | 0.150 |
Why?
|
Azepines | 1 | 2020 | 329 | 0.150 |
Why?
|
Ribosomes | 1 | 2021 | 499 | 0.150 |
Why?
|
Skull Neoplasms | 1 | 2019 | 173 | 0.150 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 117 | 0.150 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2019 | 119 | 0.150 |
Why?
|
DNA | 4 | 2022 | 7211 | 0.150 |
Why?
|
Facial Bones | 1 | 2019 | 209 | 0.150 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5713 | 0.150 |
Why?
|
DNA Damage | 2 | 2019 | 2458 | 0.150 |
Why?
|
DNA Contamination | 1 | 2017 | 19 | 0.150 |
Why?
|
Disease-Free Survival | 7 | 2021 | 6856 | 0.140 |
Why?
|
Ribosomal Proteins | 1 | 2020 | 370 | 0.140 |
Why?
|
Forkhead Transcription Factors | 5 | 2022 | 1623 | 0.140 |
Why?
|
Losartan | 1 | 2019 | 263 | 0.140 |
Why?
|
Salivary Glands | 1 | 2019 | 231 | 0.140 |
Why?
|
RANK Ligand | 1 | 2019 | 321 | 0.140 |
Why?
|
Neoplasm Invasiveness | 3 | 2022 | 3633 | 0.140 |
Why?
|
Genetic Heterogeneity | 2 | 2019 | 737 | 0.140 |
Why?
|
Histocompatibility Antigens Class I | 3 | 2024 | 1362 | 0.140 |
Why?
|
Lamin Type B | 1 | 2016 | 28 | 0.140 |
Why?
|
Prolactin | 1 | 2019 | 626 | 0.140 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 623 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2019 | 362 | 0.140 |
Why?
|
Transforming Growth Factor beta | 2 | 2023 | 2003 | 0.140 |
Why?
|
beta-Globins | 1 | 2017 | 112 | 0.130 |
Why?
|
Cell Proliferation | 7 | 2021 | 10478 | 0.130 |
Why?
|
Macrophages | 3 | 2020 | 5796 | 0.130 |
Why?
|
Androstenes | 1 | 2018 | 186 | 0.130 |
Why?
|
Liposarcoma | 1 | 2019 | 289 | 0.130 |
Why?
|
Extracellular Matrix Proteins | 1 | 2020 | 835 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2021 | 998 | 0.130 |
Why?
|
Mitotic Index | 1 | 2016 | 162 | 0.130 |
Why?
|
Mice, Nude | 3 | 2024 | 3632 | 0.130 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2015 | 83 | 0.130 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2016 | 121 | 0.120 |
Why?
|
Aged, 80 and over | 13 | 2024 | 59686 | 0.120 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2015 | 171 | 0.120 |
Why?
|
Retinoblastoma Protein | 1 | 2019 | 673 | 0.120 |
Why?
|
Neoplasm Staging | 5 | 2023 | 11254 | 0.120 |
Why?
|
Anus Neoplasms | 1 | 2019 | 337 | 0.120 |
Why?
|
Human papillomavirus 18 | 1 | 2015 | 125 | 0.120 |
Why?
|
Osteonectin | 1 | 2014 | 33 | 0.120 |
Why?
|
STAT3 Transcription Factor | 1 | 2019 | 875 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2015 | 66 | 0.120 |
Why?
|
Centromere | 1 | 2015 | 215 | 0.120 |
Why?
|
Retinal Dehydrogenase | 1 | 2014 | 78 | 0.120 |
Why?
|
Phenotype | 6 | 2023 | 16721 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2019 | 1246 | 0.110 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2014 | 104 | 0.110 |
Why?
|
Immunity, Innate | 2 | 2024 | 3078 | 0.110 |
Why?
|
Immunotherapy, Adoptive | 1 | 2024 | 1508 | 0.110 |
Why?
|
Pancreas | 1 | 2021 | 1702 | 0.110 |
Why?
|
Phenylthiohydantoin | 1 | 2015 | 208 | 0.110 |
Why?
|
Human papillomavirus 16 | 1 | 2015 | 268 | 0.110 |
Why?
|
User-Computer Interface | 1 | 2020 | 1397 | 0.110 |
Why?
|
Adult | 21 | 2024 | 223640 | 0.110 |
Why?
|
Rectal Neoplasms | 1 | 2022 | 1188 | 0.110 |
Why?
|
Graft vs Host Disease | 2 | 2023 | 3044 | 0.110 |
Why?
|
Neuroblastoma | 1 | 2021 | 1266 | 0.110 |
Why?
|
Gallbladder Neoplasms | 1 | 2015 | 191 | 0.110 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2020 | 1248 | 0.110 |
Why?
|
RNA-Binding Protein EWS | 1 | 2014 | 211 | 0.110 |
Why?
|
Gold | 1 | 2017 | 488 | 0.110 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2016 | 637 | 0.100 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 2002 | 0.100 |
Why?
|
Tissue Array Analysis | 3 | 2024 | 551 | 0.100 |
Why?
|
Lymph Nodes | 2 | 2023 | 3471 | 0.100 |
Why?
|
Haploinsufficiency | 1 | 2014 | 336 | 0.100 |
Why?
|
Metal Nanoparticles | 1 | 2017 | 405 | 0.100 |
Why?
|
RNA, Small Interfering | 3 | 2020 | 3434 | 0.100 |
Why?
|
DNA Transposable Elements | 1 | 2016 | 762 | 0.100 |
Why?
|
Lung | 2 | 2021 | 10089 | 0.100 |
Why?
|
Albumins | 1 | 2014 | 577 | 0.100 |
Why?
|
Disease Progression | 4 | 2024 | 13646 | 0.090 |
Why?
|
Transfection | 1 | 2019 | 5764 | 0.090 |
Why?
|
Camptothecin | 1 | 2015 | 593 | 0.090 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2020 | 9433 | 0.090 |
Why?
|
Microsatellite Instability | 1 | 2015 | 726 | 0.090 |
Why?
|
Placenta | 1 | 2020 | 1723 | 0.090 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 937 | 0.090 |
Why?
|
Mutation | 9 | 2022 | 30228 | 0.090 |
Why?
|
Genes, BRCA1 | 1 | 2014 | 755 | 0.090 |
Why?
|
Proteomics | 2 | 2022 | 3906 | 0.090 |
Why?
|
Monocytes | 1 | 2020 | 2595 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 620 | 0.090 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2019 | 1614 | 0.090 |
Why?
|
Genome, Human | 1 | 2023 | 4450 | 0.090 |
Why?
|
Biopsy | 5 | 2023 | 6808 | 0.090 |
Why?
|
Pancreatectomy | 3 | 2021 | 824 | 0.090 |
Why?
|
Proto-Oncogene Proteins B-raf | 4 | 2022 | 2058 | 0.080 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2012 | 410 | 0.080 |
Why?
|
T-Lymphocyte Subsets | 1 | 2018 | 1813 | 0.080 |
Why?
|
HEK293 Cells | 1 | 2019 | 4291 | 0.080 |
Why?
|
Epigenesis, Genetic | 3 | 2022 | 3827 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 3 | 2022 | 5708 | 0.080 |
Why?
|
Antiviral Agents | 1 | 2022 | 3064 | 0.080 |
Why?
|
Cause of Death | 1 | 2020 | 3728 | 0.080 |
Why?
|
Up-Regulation | 4 | 2020 | 4142 | 0.080 |
Why?
|
Neurosecretory Systems | 1 | 2011 | 223 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2022 | 4414 | 0.080 |
Why?
|
Lymphoma, B-Cell | 1 | 2015 | 945 | 0.080 |
Why?
|
Transcription Factors | 2 | 2022 | 12166 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2020 | 3112 | 0.080 |
Why?
|
Gene Knockdown Techniques | 3 | 2020 | 1608 | 0.080 |
Why?
|
Heterochromatin | 1 | 2011 | 294 | 0.080 |
Why?
|
Mucins | 2 | 2022 | 571 | 0.070 |
Why?
|
Bile Ducts, Intrahepatic | 2 | 2022 | 304 | 0.070 |
Why?
|
Promoter Regions, Genetic | 2 | 2017 | 5801 | 0.070 |
Why?
|
Neoplasm Transplantation | 3 | 2020 | 2017 | 0.070 |
Why?
|
Transplantation, Homologous | 3 | 2020 | 4834 | 0.070 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1766 | 0.070 |
Why?
|
Antineoplastic Agents | 4 | 2020 | 13697 | 0.070 |
Why?
|
Embryonic Stem Cells | 1 | 2015 | 1249 | 0.070 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6670 | 0.070 |
Why?
|
DNA Replication | 1 | 2014 | 1428 | 0.070 |
Why?
|
Serine Endopeptidases | 2 | 2024 | 1026 | 0.070 |
Why?
|
Disease Models, Animal | 6 | 2023 | 18362 | 0.070 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39407 | 0.070 |
Why?
|
Androgen Antagonists | 1 | 2015 | 1421 | 0.070 |
Why?
|
Fibroblasts | 3 | 2024 | 4177 | 0.070 |
Why?
|
Steroids | 2 | 2023 | 937 | 0.070 |
Why?
|
Autopsy | 2 | 2020 | 1013 | 0.070 |
Why?
|
RNA Interference | 1 | 2014 | 2836 | 0.060 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1967 | 0.060 |
Why?
|
Receptor, erbB-2 | 1 | 2016 | 2588 | 0.060 |
Why?
|
Histones | 1 | 2016 | 2592 | 0.060 |
Why?
|
Case-Control Studies | 3 | 2018 | 22296 | 0.060 |
Why?
|
Chromatin | 2 | 2015 | 2968 | 0.060 |
Why?
|
Carcinoma in Situ | 1 | 2011 | 789 | 0.060 |
Why?
|
Treatment Outcome | 10 | 2024 | 65379 | 0.060 |
Why?
|
Antigens, Neoplasm | 1 | 2013 | 1999 | 0.060 |
Why?
|
Automation, Laboratory | 2 | 2015 | 102 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2812 | 0.060 |
Why?
|
Mice, Knockout | 1 | 2020 | 14481 | 0.060 |
Why?
|
Immunity | 2 | 2021 | 1003 | 0.060 |
Why?
|
Transcription, Genetic | 3 | 2019 | 7599 | 0.060 |
Why?
|
Fibrosis | 2 | 2024 | 2077 | 0.060 |
Why?
|
Predictive Value of Tests | 5 | 2021 | 15455 | 0.060 |
Why?
|
Drug Delivery Systems | 1 | 2016 | 2237 | 0.060 |
Why?
|
Cadherins | 2 | 2022 | 906 | 0.060 |
Why?
|
Inflammation | 1 | 2024 | 10863 | 0.060 |
Why?
|
Repressor Proteins | 1 | 2015 | 2986 | 0.060 |
Why?
|
Short Interspersed Nucleotide Elements | 1 | 2023 | 41 | 0.060 |
Why?
|
Neuropilin-1 | 1 | 2024 | 90 | 0.060 |
Why?
|
Lymph Node Excision | 2 | 2023 | 1274 | 0.060 |
Why?
|
Gallium Radioisotopes | 1 | 2024 | 195 | 0.060 |
Why?
|
Papillomavirus Infections | 1 | 2015 | 1640 | 0.050 |
Why?
|
Arylsulfotransferase | 1 | 2023 | 27 | 0.050 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13576 | 0.050 |
Why?
|
Chronic Disease | 1 | 2018 | 9379 | 0.050 |
Why?
|
Alu Elements | 1 | 2023 | 116 | 0.050 |
Why?
|
Brain | 2 | 2020 | 27454 | 0.050 |
Why?
|
Gene Expression | 2 | 2019 | 7598 | 0.050 |
Why?
|
Minisatellite Repeats | 1 | 2023 | 164 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7453 | 0.050 |
Why?
|
Neoplastic Processes | 1 | 2022 | 36 | 0.050 |
Why?
|
Ligands | 2 | 2022 | 3283 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2830 | 0.050 |
Why?
|
Phosphorylation | 3 | 2019 | 8326 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3118 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3241 | 0.050 |
Why?
|
Sulfotransferases | 1 | 2023 | 150 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2017 | 3236 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2015 | 4785 | 0.050 |
Why?
|
Protein Isoforms | 2 | 2017 | 1703 | 0.050 |
Why?
|
Cell Line | 4 | 2019 | 15597 | 0.050 |
Why?
|
Melanoma | 1 | 2020 | 5705 | 0.050 |
Why?
|
National Institute of Child Health and Human Development (U.S.) | 1 | 2021 | 24 | 0.050 |
Why?
|
MutS Homolog 2 Protein | 1 | 2022 | 200 | 0.050 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 2021 | 47 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2014 | 4936 | 0.050 |
Why?
|
RNA Splicing | 2 | 2016 | 903 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2015 | 2923 | 0.050 |
Why?
|
Mice, Inbred C57BL | 4 | 2021 | 22355 | 0.040 |
Why?
|
Genes, MHC Class I | 1 | 2021 | 236 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5800 | 0.040 |
Why?
|
Surface-Active Agents | 1 | 2020 | 152 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2015 | 4069 | 0.040 |
Why?
|
Hyperplasia | 1 | 2023 | 1153 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2021 | 784 | 0.040 |
Why?
|
Phlebitis | 1 | 2019 | 35 | 0.040 |
Why?
|
Retinoid X Receptors | 1 | 2019 | 91 | 0.040 |
Why?
|
Mammary Glands, Animal | 1 | 2020 | 273 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2022 | 2884 | 0.040 |
Why?
|
Survival Rate | 2 | 2016 | 12870 | 0.040 |
Why?
|
Bone Marrow Transplantation | 1 | 2007 | 2709 | 0.040 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2020 | 308 | 0.040 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2019 | 66 | 0.040 |
Why?
|
Spheroids, Cellular | 1 | 2020 | 331 | 0.040 |
Why?
|
Esophagoscopy | 1 | 2020 | 398 | 0.040 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 326 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2020 | 422 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36849 | 0.040 |
Why?
|
Stem Cell Transplantation | 1 | 2007 | 1602 | 0.040 |
Why?
|
Immunotherapy | 3 | 2021 | 4738 | 0.040 |
Why?
|
Retrospective Studies | 7 | 2021 | 81801 | 0.040 |
Why?
|
E2F Transcription Factors | 1 | 2019 | 270 | 0.040 |
Why?
|
Herpesviridae | 1 | 2019 | 104 | 0.040 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2019 | 116 | 0.040 |
Why?
|
Cell Hypoxia | 1 | 2020 | 662 | 0.040 |
Why?
|
Stereotaxic Techniques | 1 | 2020 | 556 | 0.040 |
Why?
|
Germany | 1 | 2020 | 882 | 0.040 |
Why?
|
Microscopy, Electron | 1 | 2021 | 2559 | 0.040 |
Why?
|
Smad4 Protein | 1 | 2019 | 193 | 0.040 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2018 | 1536 | 0.040 |
Why?
|
Immunity, Cellular | 1 | 2023 | 1561 | 0.040 |
Why?
|
Genes, Tumor Suppressor | 1 | 2022 | 1064 | 0.040 |
Why?
|
Granzymes | 1 | 2019 | 278 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2020 | 9562 | 0.040 |
Why?
|
Endogenous Retroviruses | 1 | 2018 | 112 | 0.030 |
Why?
|
Blood Preservation | 1 | 2017 | 169 | 0.030 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2019 | 321 | 0.030 |
Why?
|
Oxidative Phosphorylation | 1 | 2019 | 501 | 0.030 |
Why?
|
RNA Probes | 1 | 2016 | 111 | 0.030 |
Why?
|
Cyclooxygenase 2 | 1 | 2019 | 599 | 0.030 |
Why?
|
Cytoprotection | 1 | 2017 | 200 | 0.030 |
Why?
|
Hematoxylin | 1 | 2016 | 61 | 0.030 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2016 | 70 | 0.030 |
Why?
|
Abdominal Neoplasms | 1 | 2018 | 287 | 0.030 |
Why?
|
Anal Canal | 1 | 2019 | 376 | 0.030 |
Why?
|
Dinoprostone | 1 | 2019 | 597 | 0.030 |
Why?
|
Epitopes | 1 | 2022 | 2525 | 0.030 |
Why?
|
Tumor Escape | 1 | 2019 | 372 | 0.030 |
Why?
|
Phenylurea Compounds | 1 | 2019 | 530 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2017 | 378 | 0.030 |
Why?
|
Survival Analysis | 2 | 2020 | 10117 | 0.030 |
Why?
|
U937 Cells | 1 | 2015 | 260 | 0.030 |
Why?
|
Plasma Cells | 1 | 2019 | 599 | 0.030 |
Why?
|
Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2015 | 17 | 0.030 |
Why?
|
Hematologic Neoplasms | 1 | 2007 | 1905 | 0.030 |
Why?
|
X Chromosome Inactivation | 1 | 2017 | 229 | 0.030 |
Why?
|
Risk Assessment | 3 | 2021 | 24318 | 0.030 |
Why?
|
gamma Catenin | 1 | 2014 | 45 | 0.030 |
Why?
|
Cell Survival | 2 | 2017 | 5792 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2021 | 1397 | 0.030 |
Why?
|
Radiotherapy | 1 | 2021 | 1509 | 0.030 |
Why?
|
Databases, Factual | 2 | 2020 | 8075 | 0.030 |
Why?
|
Protein Binding | 2 | 2019 | 9343 | 0.030 |
Why?
|
Spiral Cone-Beam Computed Tomography | 1 | 2015 | 32 | 0.030 |
Why?
|
Arginase | 1 | 2015 | 81 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2024 | 2734 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2024 | 3230 | 0.030 |
Why?
|
Platelet Activation | 1 | 2017 | 644 | 0.030 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2020 | 954 | 0.030 |
Why?
|
Nucleic Acid Hybridization | 1 | 2015 | 1305 | 0.030 |
Why?
|
Rad51 Recombinase | 1 | 2014 | 191 | 0.030 |
Why?
|
Tumor Burden | 1 | 2020 | 1913 | 0.030 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2017 | 507 | 0.030 |
Why?
|
Surface Properties | 1 | 2017 | 1167 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2016 | 628 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1794 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2019 | 3055 | 0.030 |
Why?
|
Coloring Agents | 1 | 2016 | 564 | 0.030 |
Why?
|
England | 1 | 2015 | 532 | 0.030 |
Why?
|
Centrosome | 1 | 2014 | 210 | 0.030 |
Why?
|
HLA Antigens | 1 | 2019 | 1337 | 0.030 |
Why?
|
Receptor, Notch1 | 1 | 2016 | 520 | 0.030 |
Why?
|
Apoptosis | 2 | 2021 | 9516 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2024 | 3520 | 0.030 |
Why?
|
Acute Disease | 1 | 2023 | 7242 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2066 | 0.030 |
Why?
|
Wnt2 Protein | 1 | 2012 | 28 | 0.030 |
Why?
|
Contact Inhibition | 1 | 2012 | 46 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2018 | 1093 | 0.030 |
Why?
|
Intestinal Mucosa | 1 | 2023 | 3048 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2017 | 2475 | 0.030 |
Why?
|
Propensity Score | 1 | 2020 | 1962 | 0.030 |
Why?
|
Hepatitis B, Chronic | 1 | 2017 | 413 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2020 | 2925 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2015 | 710 | 0.030 |
Why?
|
Adipogenesis | 1 | 2015 | 371 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2021 | 1597 | 0.030 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2017 | 446 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2020 | 19022 | 0.020 |
Why?
|
Wilms Tumor | 1 | 2015 | 379 | 0.020 |
Why?
|
Collagen | 1 | 2020 | 2646 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2012 | 381 | 0.020 |
Why?
|
Cell Shape | 1 | 2013 | 371 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3553 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2021 | 2448 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2014 | 720 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 13020 | 0.020 |
Why?
|
Time Factors | 2 | 2016 | 40272 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3212 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3398 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 4775 | 0.020 |
Why?
|
Metabolomics | 1 | 2020 | 1674 | 0.020 |
Why?
|
Pancreaticoduodenectomy | 1 | 2015 | 516 | 0.020 |
Why?
|
Cell Size | 1 | 2013 | 626 | 0.020 |
Why?
|
Acetylation | 1 | 2013 | 1053 | 0.020 |
Why?
|
Methylation | 1 | 2013 | 1076 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2018 | 2728 | 0.020 |
Why?
|
Autoimmunity | 1 | 2019 | 1360 | 0.020 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2012 | 252 | 0.020 |
Why?
|
Poly T | 1 | 2010 | 6 | 0.020 |
Why?
|
Genotype | 2 | 2016 | 13042 | 0.020 |
Why?
|
Melanoma, Experimental | 1 | 2014 | 559 | 0.020 |
Why?
|
Workflow | 1 | 2015 | 859 | 0.020 |
Why?
|
Genetic Markers | 1 | 2017 | 2604 | 0.020 |
Why?
|
Reverse Transcription | 1 | 2010 | 48 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2012 | 370 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 4588 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2015 | 1132 | 0.020 |
Why?
|
Culture | 1 | 2014 | 623 | 0.020 |
Why?
|
Prospective Studies | 3 | 2020 | 54920 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2017 | 3102 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20224 | 0.020 |
Why?
|
Nitriles | 1 | 2015 | 984 | 0.020 |
Why?
|
Estrogen Receptor alpha | 1 | 2014 | 581 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 906 | 0.020 |
Why?
|
Antibodies, Monoclonal | 2 | 2018 | 9261 | 0.020 |
Why?
|
Benzamides | 1 | 2015 | 1380 | 0.020 |
Why?
|
Mesoderm | 1 | 2013 | 679 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2020 | 2635 | 0.020 |
Why?
|
Tamoxifen | 1 | 2014 | 968 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2017 | 1410 | 0.020 |
Why?
|
Histone Deacetylases | 1 | 2013 | 717 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2019 | 2846 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 11918 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2015 | 1748 | 0.020 |
Why?
|
Antioxidants | 1 | 2017 | 1673 | 0.020 |
Why?
|
Pregnancy | 2 | 2021 | 30200 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2017 | 2146 | 0.020 |
Why?
|
Proteins | 1 | 2023 | 6006 | 0.020 |
Why?
|
Cell Count | 1 | 2013 | 1833 | 0.020 |
Why?
|
DNA, Viral | 1 | 2015 | 2205 | 0.020 |
Why?
|
Organ Transplantation | 1 | 2019 | 1177 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2015 | 2524 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2013 | 775 | 0.020 |
Why?
|
Paclitaxel | 1 | 2016 | 1736 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2429 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2014 | 1119 | 0.020 |
Why?
|
Prostatectomy | 1 | 2016 | 1841 | 0.020 |
Why?
|
ROC Curve | 1 | 2016 | 3623 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2014 | 1368 | 0.020 |
Why?
|
Heterozygote | 1 | 2014 | 2791 | 0.020 |
Why?
|
Cell Lineage | 1 | 2017 | 2574 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2010 | 753 | 0.020 |
Why?
|
Gene Frequency | 1 | 2014 | 3617 | 0.020 |
Why?
|
Prostate | 1 | 2015 | 1781 | 0.020 |
Why?
|
Young Adult | 3 | 2019 | 60049 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2024 | 7880 | 0.020 |
Why?
|
Cohort Studies | 2 | 2020 | 41795 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2019 | 4570 | 0.020 |
Why?
|
Pyrimidines | 1 | 2019 | 3048 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 20765 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2014 | 1667 | 0.020 |
Why?
|
United States | 3 | 2021 | 73150 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2257 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2024 | 10267 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 2017 | 1959 | 0.020 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2007 | 225 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4209 | 0.020 |
Why?
|
Breast | 1 | 2014 | 1975 | 0.020 |
Why?
|
Histocompatibility Testing | 1 | 2007 | 716 | 0.020 |
Why?
|
Skin | 1 | 2019 | 4499 | 0.020 |
Why?
|
Cytokines | 1 | 2020 | 7445 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3666 | 0.010 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2007 | 631 | 0.010 |
Why?
|
Antigens, CD | 1 | 2015 | 4031 | 0.010 |
Why?
|
Base Sequence | 1 | 2014 | 12422 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2015 | 4526 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9371 | 0.010 |
Why?
|
Logistic Models | 1 | 2017 | 13323 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2007 | 2127 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3794 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2015 | 4646 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4076 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12558 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8753 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4303 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 18048 | 0.010 |
Why?
|
Infant | 1 | 2019 | 36510 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 42650 | 0.010 |
Why?
|
Family | 1 | 2007 | 3208 | 0.010 |
Why?
|
Recurrence | 1 | 2007 | 8506 | 0.010 |
Why?
|
Child | 1 | 2019 | 80891 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 89184 | 0.010 |
Why?
|